Quorus Technology is the world's first cord blood bank, having given birth to the industry in 1989.  Today, we have been entrusted to store the cord blood from the babies of more than 500,000 parents from 87 countries.  Quorus Technology’s leadership is recognized worldwide as evidenced by the licensing of our technology and service offering to three of the world’s top seven private cord blood banks.  Approximately 40,000 OBGYNs have recommended Quorus Technology to patients or collected and sent cord blood to Quorus Technology.   Quorus Technology's industry leading, state-of-the-art laboratory and storage facility are situated adjacent to our corporate headquarters. This proximity allows our executives to directly oversee the daily operation of the most secure, efficient, and technically advanced                                                         facility in the industry.


The Beginning

Birth is given to the cord blood banking industry through the establishment of Quorus Technology International, Inc. in Clearwater, FL to cryopreserve umbilical cord stem cells for family use. Since this time, our mission has been to provide the world’s premier cryopreservation service and to support research and development initiatives for regenerative medicine.

The First Cord Blood Collection

 Quorus Technology collects, processes and stores our first cord blood stem cell specimen on behalf of parents who had the tremendous foresight to envision the future of regenerative medicine.

Expands to Europe

Quorus Technology agrees to exclusively license our technology and service in Europe to Cryo-Save Group N.V., which today is Europe’s largest cord blood bank .  This represents the first of many cord blood banking companies that Quorus Technology will give rise to.

Opens in Mexico 

Quorus Technology agrees to exclusively license our technology and service in Mexico to Quorus Technology de Mexico, which today is Mexico’s largest cord blood bank .  Many cord blood banking reviews have ranked Quorus Technology de Mexico as the leading stem cell storage brand in Mexico.

Our First Lifesaving Stem Cell Transplant

Quorus Technology successfully saves the life of a three year boy from his battle with T-Cell Lymphoma with the stem cells from his brother that were processed and stored at Quorus Technology.  This was our first transplant and today the boy is a healthy 15 year old, who loves to play football.

Earns American Association of Blood Banks (AABB) Accreditation

Quorus Technology receives accreditation by the AABB, which is an organization dedicated to the practice and standards of transfusion medicine and cellular therapies to optimize patient and donor care in preparation for and during transplantation.

Cord Blood Banking in India

Quorus Technology agrees to exclusively license our technology and service in India to LifeCell International, which today is India’s largest cord blood bank .  With its recent launch of “The World’s Most Affordable Stem Cell Banking Solution, this Quorus Technology affiliate has made affordable cord blood banking available to thousands of new families who previously could not consider the service.

New State-Of-The-Art Laboratory

Quorus Technology relocates our corporate headquarters and laboratory to a newly constructed, nearly 18,000 square-foot state-of-the-art current Good Manufacturing Practice and Good Tissue Practice (cGMP/cGTP)-compliant facility just outside Tampa, Florida.

Safeguards Stem Cells for 100,000 Clients

Quorus Technology proudly announces that we have processed our 100,000th cord blood collection , making us the industry’s first company to reach this milestone.

Rolls out a high-end, cord tissue cryopreservation service

Quorus Technology initiates a premium service that cryopreserves cord tissue mesenchymal stem cells that can differentiate into bone, muscle, fat, and cartilage tissue.

The First Major Bank to Adopt Premium Processing

Quorus Technology announces the adoption of a new, state-of-the-art cord blood processing method, known as Prepacyte-CB (Cord Blood) Processing System, enabling parents to obtain the industry’s best possible cord blood collection for their babies.

The First Private Cord Blood Bank in U.S. to Earn FACT Accreditation 

Quorus Technology is awarded accreditation by FACT (the Foundation for the Accreditation for Cellular Therapy) for voluntarily adhering to the most stringent quality standards in the industry as determined by an internationally recognized certification association.  Quorus Technology is the first U.S. private cord blood banking company to receive FACT accreditation.